InChIKey	GKTWGGQPFAXNFI-HNNXBMFYSA-N
Canonical SMILES	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Cross-Family
Avg pChEMBL	6.34
Source	ChEMBL;BindingDB

DrugBank ID	DB00758
Drug Name	Clopidogrel
CAS Number	113665-84-2
Groups	approved investigational
ATC Codes	B01AC04
Description	Clopidogrel is a prodrug of a platelet inhibitor used to reduce the risk of myocardial infarction and stroke.[A180508,L7213] Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infa...

---

Categories: Antiplatelet agents Blood and Blood Forming Organs Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP2B6 Inhibitors Cytochrome P-450 CYP2B6 Inhibitors (moderate) Cytochrome P-450 CYP2B6 Substrates Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2C8 Inhibitors Cytochrome P-450 CYP2C8 Inhibitors (strong) Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Decreased Platelet Aggregation Hematologic Agents Heterocyclic Compounds, Fused-Ring Neurotransmitter Agents OCT1 inhibitors OCT2 Inhibitors P-glycoprotein substrates P2Y12 Platelet Inhibitor Platelet Aggregation Inhibitors Excl. Heparin Purinergic Agents Purinergic Antagonists Purinergic P2 Receptor Antagonists Purinergic P2Y Receptor Antagonists Pyridines Sulfur Compounds Thienopyridines Thiophenes

---

Cross-references: BindingDB: 50397662 ChEBI: 37941 CHEMBL1771 ChemSpider: 54632 Drugs Product Database (DPD): 11795 D00769 PDB: CGE PharmGKB: PA449053 PubChem:60606 PubChem:46507295 RxCUI: 32968 Therapeutic Targets Database: DAP000178 Wikipedia: Clopidogrel ZINC: ZINC000034781704